Related Experiment Video
Updated: Jul 5, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
"Denkfaulheit" in frontotemporal dementia: a preliminary analysis
Mario F Mendez1, Jill S Shapira, Eliot A Licht
1Department of Neurology, University of California, Los Angeles, CA, USA. Mmendez@UCLA.edu
Summary
Early frontotemporal dementia (FTD) recognition is challenging due to subtle personality changes and lack of biomarkers. This study analyzes cognitive shallowness, or "Denkfaulheit," as an early indicator in FTD patients.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Frontotemporal dementia (FTD) diagnosis is often delayed due to subtle initial symptoms.
- Current diagnostic methods lack definitive early biomarkers.
- Personality changes are common but nonspecific early signs of FTD.
Purpose of the Study:
- To investigate cognitive shallowness, termed "Denkfaulheit," as a potential early marker for frontotemporal dementia.
- To analyze the manifestation of "Denkfaulheit" in the early stages of FTD.
Main Methods:
- Retrospective analysis of patient data.
- Cognitive assessments focusing on "Denkfaulheit" in early-stage FTD patients.
- Comparison with control groups (if applicable, though not specified in the abstract).
Main Results:
- Cognitive shallowness ("Denkfaulheit") was observed in patients during the early course of frontotemporal dementia.
- This cognitive trait may present subtly, complicating initial recognition.
- The findings suggest "Denkfaulheit" as a potential, albeit subtle, early indicator.
Conclusions:
- Cognitive shallowness ("Denkfaulheit") may serve as an early, though subtle, sign in frontotemporal dementia.
- Further research is warranted to validate "Denkfaulheit" as a reliable early diagnostic marker for FTD.
- Improved recognition of subtle cognitive changes like "Denkfaulheit" could aid in earlier FTD diagnosis.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:21Association Areas of the Cortex
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...